MG
RMD icon

Mather Group’s ResMed RMD Stock Holding History

Mather Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Sell
644
-70
-10% -$14.5K ﹤0.01% 886
2026
Q1 		$160K Buy
+714
New +$178K ﹤0.01% 783
2025
Q4 		– Sell
-705
Closed -$193K – 1435
2025
Q3 		$193K Buy
+705
New +$193K ﹤0.01% 627
2025
Q2 		– Sell
-692
Closed -$155K – 1478
2025
Q1 		$155K Sell
692
-15
-2% -$3.5K ﹤0.01% 658
2024
Q4 		$162K Buy
707
+6
+0.9% +$1.45K ﹤0.01% 629
2024
Q3 		$171K Buy
701
+74
+12% +$16.5K ﹤0.01% 619
2024
Q2 		$124K Buy
627
+24
+4% +$4.87K ﹤0.01% 748
2024
Q1 		$104K Buy
+603
New +$110K ﹤0.01% 695
2023
Q3 		– Sell
-1,425
Closed -$311K – 610
2023
Q2 		$311K Buy
1,425
+328
+30% +$73.1K 0.01% 452
2023
Q1 		$240K Sell
1,097
-165
-13% -$35.8K ﹤0.01% 448
2022
Q4 		$263K Sell
1,262
-291
-19% -$63.9K 0.01% 409
2022
Q3 		$339K Sell
1,553
-65
-4% -$14.8K 0.01% 346
2022
Q2 		$339K Buy
+1,618
New +$344K 0.01% 288

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mather Group's RMD Position: Q2 2026 in Review

Mather Group reduced its ResMed (RMD) stake by 9.8% in Q2 2026, selling an estimated $14.5K and leaving 644 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #886.

Mather Group first reported a position in RMD in Q2 2022 and has held it in 13 quarters since. The position peaked at $339K in Q3 2022. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Mather Group held 644 shares of ResMed worth $126K as of Q2 2026.
  • Mather Group sold 70 ResMed shares in Q2 2026, an estimated $14.5K.
  • ResMed made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #886 holding.
  • Mather Group first reported a position in ResMed in Q2 2022 and has held it in 13 quarters since.
  • Mather Group's ResMed position peaked at $339K in Q3 2022.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.